Drug Integrated Polymer Fibers Market to witness significant demand in North America

According to the recent report by Global Market Insights, Inc., drug integrated polymer fibers market size is predicted to surpass USD 88 million by the end of 2025.

Drug integrated polymer fibers are produced from polydioxanone, polylactic acid, polyglycolic acid, polycaprolactone and their derivatives. These fibers are used for orthopedic sutures, drug delivery, dermal applications and grafts & stents. They are available for a medical textile device in knitted, braided or woven form. Medical textile fibers are generally nontoxic, biodegradable, non-carcinogenic, non-allergic. The development of new yarns and fibers have expanded the application spectrum of the medical textiles field.

Request for a sample copy of this report @ https://www.gminsights.com/request-sample/detail/3103

Increased investments in healthcare infrastructure, growing population, technological advancements in medical textile sector are some factors responsible for the rising demand for drug integrated polymer fibers.

Biologics and pharma loaded fibers provide excellent mechanical support, unlike conventional drug deliver mediums like nano particles and microspheres. In addition, these fibers can be used in multi-layer formation with every layer comprising a combination of a unique polymer and drug. Pharma and biologics loaded fibers also release drugs at a slower rate in comparison to fibers of similar geometric formations. Such a diverse application range has promoted the usage of these polymer fibers.

Substantial advancements in regenerative medicine and tissue engineering, innovations in biologics and pharmaceutical products have increased the demand for drug integrated polymer fibers. Many biomedical-related applications use customized polymer fibers for meeting specific biological requirements. Therefore, the production process of these fibers depends on the application for which they will be used. For commercial applications, these fibers are manufactured using the melt extrusion method. But this method has its own set of limitations and they are addressed using a wet extrusion method. It gives these fibers positional stability and makes them ready for implant procedures.

Speaking about applications, the drug integrated polymer fibers are largely used for orthopedics. Growing geriatric population is considered the primary contributing factor for the proliferation of the segment. Elderly patients are primarily diagnosed with cardiovascular disorders and osteoarthritis which has boosted the usage of these fibers. In addition, innovations in fiber-based wound healing systems have benefitted the patients undertaking orthopedic surgeries.

Request for customization @ https://www.gminsights.com/roc/3103

Owing to the increased number of obesity and osteoporosis patients, the North America region subjugated the drug integrated polymer fibers market and is predicted to continue this trend in the coming years. Growing trend of 3D printing, advancements in robotics & smart implant technology and extensive research activities on nanotechnology have primarily contributed to the drug integrated polymer fibers market growth in the region. On the other hand, the Asia Pacific region has witnessed substantial market growth over the years. Developing nations like India, Thailand, China are potential hubs for bone grafting procedures in the future.

The only two players active in the drug integrated polymer fibers market are TissueGen Inc. and Micro Engineering Solutions. However, with the amount of potential that these fibers possess, it is highly likely that many companies will enter this market for developing products serving biomedical applications line vascular grafts, dermal wound healing, etc.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone:1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

This release was published on openPR.